Astec Lifesciences reports consolidated net loss of Rs 37.41 crore in the September 2026 quarter

Sales decline 2.31% to Rs 72.02 crore

Net Loss of Astec Lifesciences reported to Rs 37.41 crore in the quarter ended September 2026 as against net loss of Rs 24.43 crore during the previous quarter ended September 2025. Sales declined 2.31% to Rs 72.02 crore in the quarter ended September 2026 as against Rs 73.72 crore during the previous quarter ended September 2025.

Particulars	Quarter Ended
	Sep. 2026	Sep. 2025	% Var.
Sales	72.02	73.72	-2
OPM %	-27.49	-9.07	-
PBDT	-26.25	-13.97	-88
PBT	-37.43	-24.41	-53
NP	-37.41	-24.43	-53

Powered by Capital Market - Live News